![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)
针对毛囊淋巴瘤的CD19向治疗的最新进展
1Department of Medicine/Hematology Oncology, University of South Florida, Tampa, FL, USA.
Expert opinion on biological therapy
|September 18, 2024
概括
针对CD19的疗法,包括CAR-T细胞和双特异性抗体,在卵泡淋巴瘤治疗中显示出前景. 这些新的干预措施有望显著影响患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
背景情况:
- CD19是毛囊淋巴瘤中重要的治疗点.
- 新的CD19导向疗法提供了改进的治疗选择.
研究的目的:
- 审查在毛囊淋巴瘤中向CD19的作用和理由.
- 讨论各种针对CD19的干预措施及其对治疗环境的影响.
主要方法:
- 对CD19导向疗法的文献综述.
- 对单克隆抗体,双特异性抗体,抗体-药物合物和CAR T细胞疗法的分析.
- 讨论这些疗法对卵泡淋巴瘤治疗的影响.
主要成果:
- 针对CD19的疗法代表了对卵泡淋巴瘤的有希望的方法.
- 包括细胞疗法,双特异性抗体,抗体-药物合物和单克隆抗体在内的各种干预措施是有效的.
- 这些疗法预计将推进卵泡淋巴瘤治疗策略.
结论:
- CD19是毛囊淋巴瘤的验证和有吸引力的治疗点.
- 预计针对CD19的疗法将在改善患者的治疗结果方面发挥关键作用.
- 正在进行的CD19导向治疗的开发将塑造卵泡淋巴瘤管理的未来.
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:27Tumor Immunotherapy
491
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
491